Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M106,949Revenue (TTM) $M36,959Net Margin (%)0.1Altman Z-Score1.2
Enterprise Value $M131,143EPS (TTM) $0.0Operating Margin %5.3Piotroski F-Score5
P/E(ttm)--Beneish M-Score-2.6Pre-tax Margin (%)2.8Higher ROA y-yN
Price/Book14110-y EBITDA Growth Rate %0.5Quick Ratio0.6Cash flow > EarningsY
Price/Sales3.25-y EBITDA Growth Rate %-5.1Current Ratio0.9Lower Leverage y-yY
Price/Free Cash Flow53.9y-y EBITDA Growth Rate %-78.8ROA % (ttm)0.1Higher Current Ratio y-yN
Dividend Yield %5.0PEG--ROE % (ttm)0.8Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M2,436ROIC % (ttm)4.6Gross Margin Increase y-yN

Gurus Latest Trades with GSK

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GSKKahn Brothers 2016-06-30 Add2.08%$40.04 - $43.47
($42.12)
$ 43.904%Add 188.24%380,335
GSKNWQ Managers 2016-06-30 Add1.17%$40.04 - $43.47
($42.12)
$ 43.904%Add 316.61%2,075,187
GSKCharles Brandes 2016-06-30 Reduce-0.14%$40.04 - $43.47
($42.12)
$ 43.904%Reduce -5.59%4,224,506
GSKHOTCHKIS & WILEY 2016-06-30 Reduce-0.08%$40.04 - $43.47
($42.12)
$ 43.904%Reduce -5.34%8,439,389
GSKJoel Greenblatt 2016-06-30 Reduce-0.01%$40.04 - $43.47
($42.12)
$ 43.904%Reduce -49.63%25,857
GSKKen Fisher 2016-06-30 Add0.01%$40.04 - $43.47
($42.12)
$ 43.904%Add 0.63%11,730,875
GSKJohn Rogers 2016-06-30 Add0.01%$40.04 - $43.47
($42.12)
$ 43.904%Add 1.57%1,607,697
GSKTweedy Browne 2016-06-30 Add$40.04 - $43.47
($42.12)
$ 43.904%Add 0.36%116,491
GSKDodge & Cox 2016-06-30 Reduce$40.04 - $43.47
($42.12)
$ 43.904%Reduce -45.53%44,262
GSKHOTCHKIS & WILEY 2016-03-31 Reduce-0.52%$38.54 - $42.05
($39.84)
$ 43.9010%Reduce -26.34%8,915,323
GSKKahn Brothers 2016-03-31 Add0.36%$38.54 - $42.05
($39.84)
$ 43.9010%Add 55.97%131,950
GSKCharles Brandes 2016-03-31 Add0.1%$38.54 - $42.05
($39.84)
$ 43.9010%Add 3.98%4,474,409
GSKJohn Rogers 2016-03-31 Add0.05%$38.54 - $42.05
($39.84)
$ 43.9010%Add 7.17%1,582,913
GSKTweedy Browne 2016-03-31 Reduce-0.02%$38.54 - $42.05
($39.84)
$ 43.9010%Reduce -12.81%116,070
GSKNWQ Managers 2016-03-31 Add0.02%$38.54 - $42.05
($39.84)
$ 43.9010%Add 6.02%498,115
GSKKen Fisher 2016-03-31 Add0.01%$38.54 - $42.05
($39.84)
$ 43.9010%Add 1.09%11,657,855
GSKJoel Greenblatt 2016-03-31 Reduce$38.54 - $42.05
($39.84)
$ 43.9010%Reduce -1.24%51,331
GSKBarrow, Hanley, Mewhinney & Strauss 2016-03-31 Add$38.54 - $42.05
($39.84)
$ 43.9010%Add 1.12%251,800
GSKDodge & Cox 2016-03-31 Reduce$38.54 - $42.05
($39.84)
$ 43.9010%Reduce -27.95%81,262
GSKCharles Brandes 2015-12-31 Reduce-0.21%$39.1 - $43.53
($40.81)
$ 43.908%Reduce -7.92%4,303,030
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GSK is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


GSK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GLAXOSMITHKLINE PLCFormer 10% Owner 2015-02-23Sell503,150$2299.55view
GLAXOSMITHKLINE PLC10% Owner 2014-12-18Sell50,000$21.14107.66view
GLAXOSMITHKLINE PLCFormer 10% Owner (1) 2014-10-27Sell11,315,825$5.29729.87view
GLAXOSMITHKLINE PLC10% Owner 2014-04-01Buy103,762$12265.83view
GLAXOSMITHKLINE PLCFormer 10% Owner 2014-02-19Buy35,000$14213.57view
GLAXOSMITHKLINE PLCFormer 10% Shareholder 2014-02-10Buy143,773$12265.83view

Press Releases about GSK :

Quarterly/Annual Reports about GSK:

    News about GSK:

    Articles On GuruFocus.com
    GlaxoSmithKline's Dividend Health Aug 09 2016 
    Tweedy Browne 2nd Quarter Shareholder Letter Aug 01 2016 
    GlaxoSmithKline’s Sideways Dance May Pay Off in the Long Run Jul 22 2016 
    Why Berkshire Hathaway Dumped Johnson & Johnson Jul 19 2016 
    Andreas Halvorsen's Viking Global Gets Control of Stakes in 2 Companies for Backing Hot Biotech Jul 14 2016 
    Investing in Big Pharma: Pointers on Pfizer Jul 14 2016 
    Getting to Know VBI Vaccines Jul 13 2016 
    Jeff Auxier Sells Precision Castparts, AT&T, Microsoft Jun 23 2016 
    Steven Cohen Adds to Stake in Pernix Therapeutics Jun 07 2016 
    PhaseRX: The Latest Pick From a Legendary VC Firm May 24 2016 

    More From Other Websites
    Waiting For Growth, Or A Better Valuation, Argus Stays Sidelined On Novartis Shares Aug 24 2016
    Is Hikma Pharmaceuticals plc the best FTSE 100 healthcare stock to own after today’s update? Aug 24 2016
    Is AstraZeneca’s Valuation Improving Compared to Peers? Aug 23 2016
    Director/PDMR Shareholding Aug 23 2016
    Which of these Neil Woodford dividend stocks should you buy today? Aug 23 2016
    Are these 3 top stocks still mighty income machines? Aug 22 2016
    3 blue chip bargains you can’t afford to miss! Aug 22 2016
    Now is the perfect time to buy these 3 healthcare stocks! Aug 19 2016
    Glaxo/Pfizer ViiV Healthcare Starts HIV Drug Combo Study Aug 17 2016
    FTSE 100 snaps win streak, but miners cap losses Aug 16 2016
    Director/PDMR Shareholding Aug 16 2016
    ViiV Healthcare Launches Phase III Programme Evaluating a Two-drug Regimen Combining Dolutegravir... Aug 16 2016
    Is it time to take profits on GlaxoSmithKline plc and AstraZeneca plc? Aug 16 2016
    Apple Files Patent Application For A Heart-Monitoring Wearable Device Aug 12 2016
    Director/PDMR Shareholding Aug 12 2016
    Ionis (IONS) Q2 Loss Narrower than Expected, Issues Outlook Aug 10 2016
    Director/PDMR Shareholding Aug 10 2016
    Is this stock the best buy in its sector following today’s update? Aug 10 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)